SEC Form 4 · accession 0001179110-16-027677
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ji Li
Officer — EVP and Gl. Head of Bus. Dev.
Period of report
Jul 13, 2016
Accepted (ET)
Jul 15, 2016 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $2.29 | Jul 13, 2016 | A | 260,000 | A | — | Jul 12, 2026 | Ordinary Shares | 260,000 | 260,000 | D |
Explanation of responses
- F1These securities vest over a four-year period as follows: 25% on the first anniversary of July 13, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter.